Citigroup’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12K | Buy |
795
+91
| +13% | +$815 | ﹤0.01% | 4496 |
|
|
2025
Q1 | $4.44K | Sell |
704
-58
| -8% | -$366 | ﹤0.01% | 4512 |
|
|
2024
Q4 | $7.86K | Buy |
762
+61
| +9% | +$630 | ﹤0.01% | 4555 |
|
|
2024
Q3 | $9K | Buy |
701
+488
| +229% | +$6.27K | ﹤0.01% | 4502 |
|
|
2024
Q2 | $2.95K | Sell |
213
-2,165
| -91% | -$30K | ﹤0.01% | 4541 |
|
|
2024
Q1 | $739K | Sell |
2,378
-111
| -4% | -$34.5K | ﹤0.01% | 2586 |
|
|
2023
Q4 | $652K | Buy |
2,489
+1,135
| +84% | +$297K | ﹤0.01% | 2498 |
|
|
2023
Q3 | $265K | Buy |
+1,354
| New | +$265K | ﹤0.01% | 2825 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 5291 |
|
|
2021
Q2 | $0 | Sell |
1
-12
| -92% | – | ﹤0.01% | 5549 |
|
|
2021
Q1 | $8K | Sell |
13
-12
| -48% | -$7.39K | ﹤0.01% | 5093 |
|
|
2020
Q4 | $14K | Buy |
25
+17
| +213% | +$9.52K | ﹤0.01% | 4775 |
|
|
2020
Q3 | $4K | Sell |
8
-6
| -43% | -$3K | ﹤0.01% | 4759 |
|
|
2020
Q2 | $8K | Buy |
+14
| New | +$8K | ﹤0.01% | 4709 |
|